- Home
- BLMN vs LXEO Comparison
BLMN vs LXEO Comparison
Compare BLMN & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BLMN | LXEO |
|---|---|---|
| Founded | 1988 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 485.9M | 486.1M |
| IPO Year | 2012 | 2023 |
Fundamental Metrics
Financial Performance| Metric | BLMN | LXEO |
|---|---|---|
| Price | $5.22 | $5.44 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 10 |
| Target Price | $8.33 | ★ $18.60 |
| AVG Volume (30 Days) | ★ 2.8M | 767.1K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | ★ 5.70% | N/A |
| EPS Growth | ★ 106.71 | 75.08 |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $4,213,346,000.00 | $654,000.00 |
| Revenue This Year | $2.07 | N/A |
| Revenue Next Year | $1.83 | N/A |
| P/E Ratio | $52.60 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.21 | $1.45 |
| 52 Week High | $10.70 | $10.99 |
Technical Indicators
Market Signals| Indicator | BLMN | LXEO |
|---|---|---|
| Relative Strength Index (RSI) | 36.45 | 31.25 |
| Support Level | N/A | $4.93 |
| Resistance Level | $7.42 | $7.77 |
| Average True Range (ATR) | 0.31 | 0.44 |
| MACD | -0.02 | -0.07 |
| Stochastic Oscillator | 1.58 | 10.22 |
Price Performance
Historical ComparisonAbout BLMN Bloomin' Brands Inc.
Bloomin Brands Inc is a casual dining restaurant company, with a portfolio of, differentiated restaurant concepts. Its restaurant portfolio includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill and Fleming's Prime Steakhouse & Wine Bar. Its restaurant concepts range in price point and degree of formality from casual (Outback Steakhouse and Carrabba's Italian Grill) to polished casual (Bonefish Grill) and fine dining (Fleming's Prime Steakhouse & Wine Bar). The U.S. segment includes all restaurants operating in the U.S. while franchised restaurants operating outside the U.S. are included in the international franchise segment.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.